Last reviewed · How we verify

Conventional glucocorticoid therapy — Competitive Intelligence Brief

Conventional glucocorticoid therapy (Conventional glucocorticoid therapy) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Glucocorticoid. Area: Immunology, Rheumatology, Endocrinology.

marketed Glucocorticoid Glucocorticoid receptor (GR) Immunology, Rheumatology, Endocrinology Small molecule Live · refreshed every 30 min

Target snapshot

Conventional glucocorticoid therapy (Conventional glucocorticoid therapy) — University of Roma La Sapienza. Glucocorticoids suppress immune and inflammatory responses by binding to glucocorticoid receptors and modulating gene expression of pro-inflammatory cytokines and immune cells.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Conventional glucocorticoid therapy TARGET Conventional glucocorticoid therapy University of Roma La Sapienza marketed Glucocorticoid Glucocorticoid receptor (GR)
Medrol methylprednisolone Generic (originally Upjohn/Pfizer) marketed Glucocorticoid (corticosteroid) Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor 1957-10-01
Prelone prednisolone Generic (originally Schering) marketed Glucocorticoid (corticosteroid) Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1 1955-01-01
Prednisone/Prednisolone/Methylprednisolone Prednisone/Prednisolone/Methylprednisolone Hoffmann-La Roche marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Intravenous Dexamethasone Intravenous Dexamethasone University of British Columbia marketed Glucocorticoid (corticosteroid) Glucocorticoid receptor (GR)
Methylprednisolone (drug) Methylprednisolone (drug) University Hospital, Bordeaux marketed Glucocorticoid (corticosteroid) Glucocorticoid receptor (GR)
Methylprednisolone (MP) Methylprednisolone (MP) Masonic Cancer Center, University of Minnesota marketed Glucocorticoid (corticosteroid) Glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Glucocorticoid class)

  1. Research in Real-Life Ltd · 2 drugs in this class
  2. NICHD Neonatal Research Network · 2 drugs in this class
  3. UMC Utrecht · 2 drugs in this class
  4. University of Pennsylvania · 2 drugs in this class
  5. First Affiliated Hospital of Zhejiang University · 1 drug in this class
  6. GlaxoSmithKline · 1 drug in this class
  7. ClinAmygate · 1 drug in this class
  8. Instituto de Investigación Sanitaria y Biomédica de Alicante · 1 drug in this class
  9. First Affiliated Hospital of Wenzhou Medical University · 1 drug in this class
  10. Guangzhou JOYO Pharma Co., Ltd · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Conventional glucocorticoid therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/conventional-glucocorticoid-therapy. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: